Summary
Vaccination against Japanese encephalitis has been carried out extensively in many Asian countries for the past 20 years and is also increasingly recommended for travellers to endemic areas. Although the currently available vaccine, manufactured from mouse brain, is generally considered to be highly effective and of low reactogenicity, approximately 50% of vaccinees report experiencing usually mild adverse effects following vaccination. Concern has been raised regarding potential neurological adverse effects but the incidence of such effects appears to be very low (around 1 to 2.3 per 1 000 000 vaccinations). Routine vaccination of all travellers to endemic areas is clearly not beneficial at this moment and use of the vaccine should remain restricted to persons spending a month or longer in endemic areas, especially rural areas, during the transmission season. However, when counselling individual travellers, it has to be kept in mind that the possibility of Japanese encephalitis can never be ruled out completely when travelling to endemic areas, and that such an infection can prove disastrous for the individual concerned.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Japanese encephalitis: Inactivated Japanese encephalitis virus vaccine. Wkly Epidemiol Rec 1994; 69(16): 113–8
Inactivated Japanese encephalitis virus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993; 42(RR-1): 1–15
Igarashi A. Epidemiology and control of Japanese encephalitis. World Health Stat Q 1992; 45(2-3): 299–305
Umenai T, Krzysko R, Bektimirov A, et al. Japanese encephalitis: current worldwide status. Bull World Health Organ 1985; 63: 623–31
Monath T. Japanese encephalitis — a plague of the orient. N Engl J Med 1988; 319: 641–3
Okuno T. An epidemiological review of Japanese encephalitis. World Health Stat Q 1978; 3: 120–31
Thogcharoen P. Japanese encephalitis virus encephalitis: an overview. Southeast Asian J Trop Med Public Health 1989; 20: 559–73
Rosen L. The natural history of Japanese encephalitis virus. Annu Rev Microbiol 1986; 40: 395–414
Sucharit S, Surathin K, Shrestha S. Vectors of Japanese encephalitis virus (JEV): species complexes of the vectors. Southeast Asian J Trop Med Public Health 1989; 20: 611–21
Hoke C, Nisalak A, Sangawhipa N, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988; 319: 608–14
Macdonald W, Tink A, Ouvrier R. Japanese encephalitis after a two-week holiday in Bali. Med J Aust 1989; 150: 334–7
Wittesjö B, Eitrem R, Niklasson B, et al. Japanese encephalitis after a 10-day holiday in Bali. Lancet 1995; 345: 856–7
Oya A. Japanese encephalitis vaccine. Acta Pediatr Jpn 1988; 30: 175–84
Rojanasuphot S, Charoensuk O, Kityprayura D. A field trial of Japanese encephalitis virus vaccine produced in Thailand. Southeast Asian J Trop Med Public Health 1989; 20: 653–4
Rao Bhau L, Singh F, Gowal D. Safety and efficacy of Japanese encephalitis vaccine produced in India. Indian J Med Res 1988; 88: 301–7
Shepard D, Halstead S. Dengue. In: Jamison DT, Mosley WH, Measham AR, et al., editors. Disease control priorities in developing countries. New York: Oxford University Press Inc., 1993: 303–30
Tsai T, Yu Y. Japanese encephalitis vaccines. In: Plotkin S, Mortimer EJ, editors. Vaccines. 2nd ed. Philadelphia: WB Saunders, 1995: 671–713
Luo D, Yin H, Xili L, et al. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study. Southeast Asian J Trop Med Public Health 1994; 25(4): 643–6
Hennessy S, Zehngle L, Tsai T, et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA 14-14-2): a case control study. Lancet 1996; 347: 1583–6
Steinhoff M. Japanese Encephalitis: a Chinese solution? Lancet 1996; 347: 1570–1
Poland J, Cropp C, Craven R, et al. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis 1990; 161: 878–82
Sanchez J, Hoke C, McCowan J. Further experience with Japanese encephalitis vaccine. Lancet 1990; 335: 972–3
Japanese encephalitis vaccine and adverse effects among travellers. Can Dis Wkly Rep 1991; 17: 173–7
Ohtaki E, Murakami Y, Komori H, et al. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr Neurol 1992; 8(2): 137–9
Andersen MM, Rönne T. Side-effects with Japanese encephalitis vaccine [letter]. Lancet 1991; 337 (8748): 1044
Ruff TA, Eisen D, Fuller A, et al. Adverse reactions to Japanese encephalitis vaccine [letter]. Lancet 1991; 338(8771): 881–2
Nothdurft HD, Jelinek T, Marschang A, et al. Adverse reactions to Japanese encephalitis vaccine in German travellers. J Infect 1996; 32: 119–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jelinek, T., Nothdurft, H.D. Japanese Encephalitis Vaccine in Travellers. Drug-Safety 16, 153–156 (1997). https://doi.org/10.2165/00002018-199716030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199716030-00001